# Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry

> **NCT03326076** · — · UNKNOWN · sponsor: **CareDx** · enrollment: 4000 (estimated)

## Conditions studied

- Kidney Transplant Rejection

## Interventions

- **DIAGNOSTIC_TEST:** Donor-derived cell-free DNA (AlloSure®)
- **OTHER:** Standard care
- **DIAGNOSTIC_TEST:** Peripheral blood gene expression profiling (AlloMap Kidney)
- **DIAGNOSTIC_TEST:** Analytic platform (IBox)

## Key facts

- **NCT ID:** NCT03326076
- **Lead sponsor:** CareDx
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-23
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 4000 (ESTIMATED)
- **Last updated:** 2023-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03326076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03326076, "Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03326076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*